← back to search

Eduardo Nagore

Universitat de València · ES
Area of research
Oncology · Epidemiology
Research interest
Research interests include Cutaneous Melanoma Detection and Management, Nonmelanoma Skin Cancer Studies, Melanoma and MAPK Pathways, and melanin and skin pigmentation.
h-index
50
citations
13,939
works
537
NIH funding
primary concept
email

Recent publications

Stromal lipid species dictate melanoma metastasis and tropism
Cancer Cell 2025cited by 27position: middledoi
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance
JCO Precision Oncology 2024cited by 6position: middledoi
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023
European Journal of Cancer 2023cited by 255position: middledoi
Delphi Consensus Among International Experts on the Diagnosis, Management, and Surveillance for Lentigo Maligna
Dermatology Practical & Conceptual 2023cited by 15position: middledoi
Landscape of mutations in early stage primary cutaneous melanoma: An <scp>InterMEL</scp> study
Pigment Cell & Melanoma Research 2022cited by 21position: middledoi
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia
Genetics in Medicine 2021cited by 41position: middledoi
Molecular characterization of fast-growing melanomas
Journal of the American Academy of Dermatology 2021cited by 14position: middledoi
Longitudinal study of prognostic factors for localized cutaneous melanoma in patients who have been disease-free for five years
European Journal of Dermatology 2021cited by 3position: lastdoi
Positive Attributes of Anti-TERT CD4 T-Helper Type 1 Immune Responses in Melanoma
Journal of Investigative Dermatology 2021cited by 2position: firstdoi
MOLECULAR LANDSCAPE OF OLD AGE MELANOMA BY SURVIVAL AND IMMUNOTHERAPY RESPONSE
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 0position: middledoi
Risk factors for the development of a second melanoma in patients with cutaneous melanoma
Journal of the European Academy of Dermatology and Venereology 2020cited by 31position: lastdoi
Clinical, environmental and histological distribution of<i>BRAF</i>,<i>NRAS</i>and<i>TERT</i>promoter mutations among patients with cutaneous melanoma: a retrospective study of 563 patients*
British Journal of Dermatology 2020cited by 25position: lastdoi
Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma
Scientific Reports 2020cited by 23position: middledoi
Association of HERV-K and LINE-1 Hypomethylation with Reduced Disease-Free Survival in Melanoma Patients
Epigenomics 2020cited by 13position: middledoi
MC1R variants and cutaneous melanoma risk according to histological type, body site, and Breslow thickness: a pooled analysis from the M-SKIP project
Melanoma Research 2020cited by 12position: middledoi
Mutation Signatures in Melanocytic Nevi Reveal Characteristics of Defective DNA Repair
Journal of Investigative Dermatology 2020cited by 9position: middledoi
Informing patients about their mutation tests: CDKN2A c.256G&gt;A in melanoma as an example
Hereditary Cancer in Clinical Practice 2020cited by 4position: middledoi
Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines
European Journal of Cancer 2019cited by 584position: middledoi
Risk Factors for Lymphatic and Hematogenous Dissemination in Patients With Stages I to II Cutaneous Melanoma
JAMA Dermatology 2019cited by 38position: lastdoi
TERT promoter mutations in melanoma survival
Oncotarget 2019cited by 28position: firstdoi
TERT Promoter Mutations are Associated with Visceral Spreading in Melanoma of the Trunk
Cancers 2019cited by 21position: middledoi
MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort
The Lancet Child & Adolescent Health 2019cited by 19position: middledoi
TERT promoter mutation subtypes in 20 in-situ melanomas
Melanoma Research 2019cited by 2position: lastdoi
Error in Title of Letter to the Editor
JAMA Dermatology 2019cited by 1position: firstdoi
Error in Corresponding Authorship
JAMA Dermatology 2019cited by 1position: firstdoi
Abstract 3994: Genomic characterization of melanoma in the elderly reveals molecular drivers of progression and prognosis associated with immunotherapy response
Cancer Research 2019cited by 0position: middledoi
Lymphatic and Hematogenous Dissemination in Patients With Primary Cutaneous Melanoma—Reply
JAMA Dermatology 2019cited by 0position: firstdoi
Coding and noncoding somatic mutations in basal cell carcinoma
bioRxiv (Cold Spring Harbor Laboratory) 2019cited by 0position: middledoi
Sleep-Disordered Breathing Is Independently Associated With Increased Aggressiveness of Cutaneous Melanoma
CHEST Journal 2018cited by 65position: middledoi
Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk
Genes Chromosomes and Cancer 2018cited by 55position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Rajiv Kumar · National Remote Sensing Centre49 papers (2012–2021) · 31 papers (2012–2021) · 24 papers (2013–2021) · 19 papers (2013–2021)P. Sivaramakrishna Rachakonda · Universitätsklinikum Tübingen16 papers (2012–2020)Barbara Heidenreich · All-Russian Scientific Research Institute of Fundamental and Applied Parasitology of Animals and Plants named after K.I. Skryabin13 papers (2014–2020)Kari Hemminki · Lund University9 papers (2012–2020)Nalini Srinivas · German Cancer Research Center7 papers (2018–2020)Amaya Virós · University of Manchester6 papers (2017–2021) · 6 papers (2012–2020)Vincent Soriano · Centre for Plant Biotechnology and Genomics6 papers (2015–2019)Dirk Schadendorf · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori5 papers (2012–2018)Justo Lorenzo Bermejo · University Hospital Heidelberg4 papers (2012–2013) · 4 papers (2015–2020) · 4 papers (2019–2020)Nelleke A. Gruis · Yale Cancer Center4 papers (2015–2020) · 4 papers (2012–2018)Maria Concetta Fargnoli · Università Campus Bio-Medico4 papers (2015–2020) · 3 papers (2018–2020)Anders Molven · University of Oslo3 papers (2018–2020)